Page last updated: 2024-10-30

edaravone and Long QT Syndrome

edaravone has been researched along with Long QT Syndrome in 1 studies

Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Shimizu, H1
Inoue, S1
Endo, M1
Nakamaru, Y1
Yoshida, K1
Natori, T1
Kakubari, M1
Akimoto, M1
Kondo, K1

Trials

1 trial available for edaravone and Long QT Syndrome

ArticleYear
A Randomized, Single-Blind, Placebo-Controlled, 3-Way Crossover Study to Evaluate the Effect of Therapeutic and Supratherapeutic Doses of Edaravone on QT/QTc Interval in Healthy Subjects.
    Clinical pharmacology in drug development, 2021, Volume: 10, Issue:1

    Topics: Adult; Cross-Over Studies; Edaravone; Electrocardiography; Free Radical Scavengers; Healthy Voluntee

2021